GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization

Robert J Harvey; U B Depner; H Wässle; S Ahmadi; C Heindl; H Reinold; T G Smart; K Harvey; B Schütz; O M Abo-Salem; A Zimmer; P Poisbeau; H Welzl; D P Wolfer; H Betz; H U Zeilhofer; U Müller

doi:10.1126/science.1094925

Back

GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization

Journal article

Peer reviewed

GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization

Robert J Harvey, U B Depner, H Wässle, S Ahmadi, C Heindl, H Reinold, T G Smart, K Harvey, B Schütz, O M Abo-Salem, …

Science, Vol.304(5672), pp.884-887

2004

DOI: https://doi.org/10.1126/science.1094925

Files and links (1)

url

https://doi.org/10.1126/science.1094925View

Published Version

Abstract

biochemistry

drug therapy

neurology

pain sensitization

phosphorylation

Prostaglandin E2 (PGE2) is a crucial, mediator of inflammatory pain sensitization. Here, we demonstrate that inhibition of a specific glycine receptor subtype (GlyR α3) by PGE2-induced receptor phosphorylation underlies central inflammatory pain sensitization. We show that GlyR α3 is distinctly expressed in superficial layers of the spinal cord dorsal horn. Mice deficient in GlyR α3 not only lack the inhibition of glycinergic neurotransmission by PGE2 seen in wild-type mice but also show a reduction in pain sensitization induced by spinal, PGE2 injection or peripheral, inflammation. Thus, GlyR α3 may provide a previously unrecognized molecular target in pain therapy.

Details

Title: GlyR α3: An Essential Target for Spinal PGE2-Mediated Inflammatory Pain Sensitization
Authors: Robert J Harvey (Author) - School of Pharmacy, United Kingdom
U B Depner (Author) - Universität Erlangen-Nürnberg, Germany
H Wässle (Author) - Max-Planck-Institut für Hirnforschung, Germany
S Ahmadi (Author) - Universität Erlangen-Nürnberg, Germany
C Heindl (Author) - Universität Erlangen-Nürnberg, Germany
H Reinold (Author) - Universität Erlangen-Nürnberg, Germany
T G Smart (Author) - University College London, United Kingdom
K Harvey (Author) - School of Pharmacy, United Kingdom
B Schütz (Author) - Universitätsklinikum Bonn, Germany
O M Abo-Salem (Author) - Universitätsklinikum Bonn, Germany
A Zimmer (Author) - Universitätsklinikum Bonn, Germany
P Poisbeau (Author) - Université Louis Pasteur, France
H Welzl (Author) - Universität Zürich-Irchel, Switzerland
D P Wolfer (Author) - Universität Zürich-Irchel, Switzerland
H Betz (Author) - Max-Planck-Institut für Hirnforschung, Germany
H U Zeilhofer (Author) - Universität Erlangen-Nürnberg, Germany
U Müller (Author) - Max-Planck-Institut für Hirnforschung, Germany
Publication details: Science, Vol.304(5672), pp.884-887
Publisher: American Association for the Advancement of Science
Date published: 2004
DOI: 10.1126/science.1094925
ISSN: 0036-8075
Organisation Unit: School of Health; University of the Sunshine Coast, Queensland; School of Health and Sport Sciences - Legacy; Centre for Bioinnovation; School of Health and Behavioural Sciences - Legacy
Language: English
Record Identifier: 99450803502621
Output Type: Journal article

Metrics

1 File views/ downloads

1083 Record Views

502 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Web Of Science research areas: Neurosciences

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites